Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru, M Varroud-Vial… - Diabetes & …, 2003 - Elsevier
OBJECTIVES: 33 years after the UGDP study, the question of deleterious effects of the
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
[PDF][PDF] Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru, M Varroud-Vial… - Diabetes Metab, 2003 - Citeseer
Objectives: 33 years after the UGDP study, the question of deleterious effects of the
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
[引用][C] Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru, M Varroud-Vial… - Diabetes & …, 2003 - cir.nii.ac.jp
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data
in humans and clinical applications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
in humans and clinical applications | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru… - Diabetes & …, 2003 - pubmed.ncbi.nlm.nih.gov
Objectives 33 years after the UGDP study, the question of deleterious effects of the
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
[引用][C] Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP RIVELINE, N DANCHIN, F LEDRU… - Diabetes & …, 2003 - pascal-francis.inist.fr
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available
data in humans and clinical applications CNRS Inist Pascal-Francis CNRS Pascal and …
data in humans and clinical applications CNRS Inist Pascal-Francis CNRS Pascal and …
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline, N Danchin, F Ledru, M Varroud-Vial… - Diabetes and …, 2003 - infona.pl
33 years after the UGDP study, the question of deleterious effects of the sulfoylurea (SU) is
still raised. We have made a systematic review of the literature from experimental studies to …
still raised. We have made a systematic review of the literature from experimental studies to …
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications.
JP Riveline, N Danchin, F Ledru… - Diabetes & …, 2003 - europepmc.org
Objectives 33 years after the UGDP study, the question of deleterious effects of the
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
sulfoylurea (SU) is still raised. We have made a systematic review of the literature from …
[引用][C] Sulfonylureas and cardiovascular effects: from experimental data to clinical use. available data in humans and clinical applications
R JP - Diabetes Metab., 2003 - cir.nii.ac.jp
Sulfonylureas and cardiovascular effects : from experimental data to clinical use. available
data in humans and clinical applications | CiNii Research CiNii 国立情報学研究所 学術情報 …
data in humans and clinical applications | CiNii Research CiNii 国立情報学研究所 学術情報 …